More executional capabilities derive from affiliation with parent, inVentiv Health
Calling today’s healthcare market “complex, crowded and competitive,” Campbell Alliance, the consulting arm of inVentiv Health (New York) has reorganized its launch services as the Launch Suite. The company has a track record of assisting brand owners in product launches, claiming a 45% improvement in time-to-launch over the past decade for its clients. Key to this was the development of the branded Launch Playbook, a software-based project-management and analytic tool to organize diverse launch activities successfully. With a predicted 400 product launches expected over the next three years globally—and with the awareness that what happens at the moment of launch sets the parameters for the commercial performance of most new drugs—managing the launch process is crucial.
Yet, says Rohit Sood, head of Global Launch Excellence at Campbell, the life sciences industry is constrained by a relatively low number of launches in the past few years at Big Pharma companies, and the lack of experience and resources at emerging pharma companies. (FDA announced 41 new-molecular-entity drug approvals in 2014—a record not matched since the mid-1990s.) Sood says that the reorganized Launch Suite will be able to provide a wider array of execution services by bringing in other parts of the inVentiv organization (which acquired Campbell in 2011), such as medical affairs and contract sales, but the emphasis will still be on strategic consulting. The company’s Launch Playbook has been expanded and updated, and Campbell shares this resource with clients while helping them organize their internal efforts. (There is some discussion of whether to offer the Launch Playbook as a standalone product, but, as Sood says, “we’re not in the IT business.”)
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.